Patients with advanced and nonadvanced adenomas are at an increased risk for CRC, but only those with advanced adenomas had ...

Practising Optometrist, Dr Lynda Lucky, is fight­ing the battle of her life as she confronts colon cancer. The ebullient eye doctor frantically needs Seventeen mil­lion Naira (N17m) to fund cancer ...

Dysregulation of mitochondrial reactive oxygen species (mtROS) contributes to intestinal tumorigenesis. Here the authors report that excessive mtROS induces the release of mitochondrial PGAM5 into ...

Monoallelic loss of PTEN and ARID1A is identified in normal colonic epithelium. The resulting haploinsufficient phenotypes ...

Using a novel, medication-based approach, a new Northwestern Medicine study published in the Journal of Clinical Investigation successfully reversed existing inguinal hernias in male mice and ...

1Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. *Corresponding Author: John Paul Shen, Department of Colon and Rectal Surgery, The ...

Adenomatous polyps typically do not cause symptoms unless they progress to colon cancer. Even then, there may be no sign of a problem until the malignancy is advanced. This is why colon cancer ...

He is a native English speaker. A blood test that accurately detects colon cancer in middle-aged and older people and also rules it out when it is not present can help to increase the rate of ...

Abstract: Addressing the formidable challenges posed by the diagnosis and management of various types of cancer, including breast, colon, lung, and colorectal cancer ... specifically tailored to the ...

Nancy Leftenant-Colon, who battled racial discrimination in a barrier-breaking career as a military nurse, serving as the first African American in the regular Army Nurse Corps and later caring ...

Single-cycle neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: Final analysis of the RESET-C study. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Safety and tolerability of different total neoadjuvant therapy strategies in patients with locally advanced rectal cancer. First-in-human, phase 1a, dose escalation study of BGB-B167, a CEA x 4-1BB ...